171 related articles for article (PubMed ID: 33190261)
1. Developments over the last 60 years in diffuse large B-cell lymphomas.
Linch D
Br J Haematol; 2020 Nov; 191(4):552-557. PubMed ID: 33190261
[TBL] [Abstract][Full Text] [Related]
2. Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years.
Loh Z; Salvaris R; Chong G; Churilov L; Manos K; Barraclough A; Hawkes EA
Br J Haematol; 2021 May; 193(4):741-749. PubMed ID: 33851428
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma.
Martelli M; Ferreri AJ; Agostinelli C; Di Rocco A; Pfreundschuh M; Pileri SA
Crit Rev Oncol Hematol; 2013 Aug; 87(2):146-71. PubMed ID: 23375551
[TBL] [Abstract][Full Text] [Related]
4. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
O'Malley DP; Auerbach A; Weiss LM
Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma.
Papageorgiou SG; Thomopoulos TP; Spathis A; Bouchla A; Glezou I; Stavroulaki G; Gkontopoulos K; Bazani E; Foukas PG; Pappa V
Hematol Oncol; 2019 Dec; 37(5):634-637. PubMed ID: 31657017
[No Abstract] [Full Text] [Related]
6. The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paper.
McKay P; Wilson MR; Chaganti S; Smith J; Fox CP; Cwynarski K;
Br J Haematol; 2020 Sep; 190(5):708-714. PubMed ID: 32433789
[No Abstract] [Full Text] [Related]
7. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.
Huntington SF; Hoag JR; Zhu W; Wang R; Zeidan AM; Giri S; Podoltsev NA; Gore SD; Ma X; Gross CP; Davidoff AJ
Cancer; 2018 Nov; 124(21):4211-4220. PubMed ID: 30216436
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
9. The Spectrum of Double Hit Lymphomas.
Abramson JS
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1239-1249. PubMed ID: 27888878
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of the prognostic nutritional index in very elderly patients over 80 years of age with diffuse large B-cell lymphoma.
Hamada E; Shinji O; Nishiyama-Fujita Y; Akiimoto M; Tanigawa T; Ito C; Sakurai A; Aisa Y; Nakazato T
Ann Hematol; 2020 May; 99(5):1153-1155. PubMed ID: 32270216
[No Abstract] [Full Text] [Related]
12. Primary Diffuse Large B-cell Lymphoma involving the Mandible.
Alshahrani FA; Aljabab AS; Motabi IH; Alrashed A; Anil S
J Contemp Dent Pract; 2015 Oct; 16(10):840-4. PubMed ID: 26581467
[TBL] [Abstract][Full Text] [Related]
13. Clinical approach to diffuse large B cell lymphoma.
Caimi PF; Hill BT; Hsi ED; Smith MR
Blood Rev; 2016 Nov; 30(6):477-491. PubMed ID: 27596109
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication.
Tari A; Asaoku H; Kashiwado K; Yoshino T; Kitadai Y; Tanaka S; Fujihara M
Dig Endosc; 2009 Oct; 21(4):219-27. PubMed ID: 19961519
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
[TBL] [Abstract][Full Text] [Related]
17. Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population.
Naeini YB; Wu A; O'Malley DP
Ann Diagn Pathol; 2016 Dec; 25():7-14. PubMed ID: 27806850
[TBL] [Abstract][Full Text] [Related]
18. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
19. Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.
Chiappella A; Castellino A; Nicolosi M; Santambrogio E; Vitolo U
Expert Rev Hematol; 2017 Apr; 10(4):289-297. PubMed ID: 28290728
[TBL] [Abstract][Full Text] [Related]
20. De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course.
Ramachandran P; Sahni S; Wang JC
J Investig Med High Impact Case Rep; 2019; 7():2324709619893546. PubMed ID: 31814435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
